Fig. 1From: Linagliptin inhibits lipopolysaccharide-induced inflammation in human U937 monocytesEffects of linagliptin treatment on lipopolysaccharide (LPS)-induced interleukin (IL)-6 production after 24 h. Human U937 monocytes were treated with LPS and/or linagliptin. IL-6 levels in the supernatants were determined via enzyme-linked immunosorbent assay (ELISA) after 24 h of treatment. *P < 0.0001 vs. control; †P < 0.0001 vs. LPS 1 μg/mL. Lina, linagliptinBack to article page